Contribution of cholesterol 7α-hydroxylase to the regulation of lipoprotein metabolism

Current Opinion in Lipidology

Volumn 10, Issue 4, 1999, Pages 303-307

  Cohen, Jonathan C ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Center for Human Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGENASE; CHOLESTEROL 7ALPHA MONOOXYGENASE;

ALLELE; BILE ACID SYNTHESIS; ENTEROHEPATIC CIRCULATION; ENZYME ACTIVITY; GENE INACTIVATION; GENETIC VARIABILITY; HAMSTER; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; ANIMAL; BLOOD; GENETIC POLYMORPHISM; GENETICS; METABOLISM; REVIEW;

CRICETINAE;

ANIMALS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL, LDL; HUMANS; LIPOPROTEINS; POLYMORPHISM, GENETIC;

EID: 0032587838     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199908000-00003     Document Type: Short Survey

References (21)

1. Schwarz M, Lund EG, Russell DW. Two 7 alpha-hydroxylase enzymes in bile acid biosynthesis. Curr Opin Lipidol 1998; 9:113-118.
2. Reihner E, Angelin B, Rudling M, Ewerth S, Bjorkhem I, Einarsson K. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 1990; 31:2219-2226.
3. Ode H, Yamashita H, Kosahara K, Kuroki S, Nakayama F. Esterified and total 7 alpha-hydroxycholesterol in human serum as an indicator for hepatic bile acid synthesis. J Lipid Res 1990; 31:2209-2218.
4. Nicolau G, Shefer S, Salen G, Mosbach EH. Determination of hepatic cholesterol 7 alpha-hydroxylase activity in man. J Lipid Res 1974; 15:146-151.
5. Bjorkhem I, Reihner E, Angelin B, Ewerth S, Akerlund JE, Einarsson K. On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J Lipid Res 1987; 28:889-894.
6. Ast M, Frishman WH. Bile acid sequestrants. J Clin Pharmacol 1990; 30:99-106.
7. Einarsson K, Ericsson S, Ewerth S, Reihner E, Rudling M, Stahlberg D, Angelin B. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism. Eur J Clin Pharmacol 1991; 40 (Suppl 1):S53-S58.
8. Schwarz M, Lund EG, Lathe R, et al. Identification and characterization of a mouse oxysterol 7 alpha-hydroxylase cDNA. J Biol Chem 1997; 272:23995-24001.
9. Bertolotti M, Abate N, Loria P, et al. Regulation of bile acid synthesis in humans: studies on cholesterol 7 alpha-hydroxylation in vivo. Ital J Gastroenterol 1995; 27:446-449.
10. Bertolotti M, Carulli N, Menozzi D, Zironi F, Digrisolo A, Pinetti A, Baldini MG. In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment. J Lipid Res 1986; 27:1278-1286.
11. Bertolotti M, Abate N, Bertolotti S, Loria P, Concari R, Messora F, et al. Effect of aging on cholesterol 7 alpha-hydroxylation in humans. J Lipid Res 1993; 34:1001-1007.
12. Bertolotti M, Abate N, Loria P. Dilengite F, Carubbi A, Pinetti A, et al. Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. Hepatology 1991; 14:830-837.
13. Setchell KD, Schwarz M, O'Connell NC, Lund EG, Davis DL, Lathe R, et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7 alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 1998; 102:1690-1703. The authors provide a detailed phenotypic and genetic characterization of oxysterol 7 alpha-hydroxylase deficiency.
14. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7 alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 1998; 101:1283-1291. The authors demonstrate linkage studies in a large group of nuclear families. Both linkage and association between CYP7A1 and plasma LDL-cholesterel are demonstrated.
15. Spady DK, Cuthbert JA, Willard MN, Meidell RS. Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest 1995; 96:700-709.
16. Spady DK, Cuthbert JA, Willard MN, Meidell RS. Overexpression of cholesterol 7 alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced. J Biol Chem 1998; 273:126-132. The authors provide a detailed characterization of the effects of transient overexpression of CYP7A1 on cholesterol metabolism and transport.
17. Moore GL, Drevon CA, Machleder D, Trawick JD, McClelland A, Roy S, et al. Expression of human cholesterol 7 alpha-hydroxylase in atherosclerosis-susceptible mice via adenovirus infection. Biochem J 1997; 324:863-867.
18. Agellon LB. Partial transfection of liver with a synthetic cholesterol 7 alpha-hydroxylase transgene is sufficient to stimulate the reduction of cholesterol in the plasma of hypercholesterolemic mice. Biochem Cell Biol 1997; 75:255-262.
19. Vega GL, Grundy SM. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol. JAMA 1987; 257:33-38.
20. Schwarz M, Lund EG, Setchell KR, Kayden HJ, Zerwekh JE, Bjorkhem I, et al. Disruption of cholesterol 7 alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J Biol Chem 1996; 271:18024-18031.
21. Schwarz M, Russell DW, Dietschy JM, Turley SD. Marked reduction in bile acid synthesis in cholesterol 7 alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J Lipid Res 1998; 39:1833-1843. The authors provide a detailed characterization of the effects of CYP7A1 deficiency on cholesterol and bile acid metabolism.